Tuberculosis drug resistance testing by molecular methods: Opportunities and challenges in resource limited settings

Journal of Microbiological Methods

Volumn 84, Issue 2, 2011, Pages 155-160

  Abebe, Gemeda ^a,b   Paasch, Fabienne ^b   Apers, Ludwig ^c   Rigouts, Leen ^c   Colebunders, Robert ^b,c  

^a JIMMA UNIVERSITY   (Ethiopia)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

Drug resistance; Resource limited settings; Tuberculosis

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; CAPREOMYCIN; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; MACROLIDE; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; DNA MICROARRAY; DNA SEQUENCE; DRUG RESISTANT TUBERCULOSIS; HUMAN; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOBACTERIUM TUBERCULOSIS;

BACILLI (CLASS);

EID: 79251604956     PISSN: 01677012     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mimet.2010.11.014     Document Type: Review

References (85)

1. Ahmad S., et al. Comparison of performance of two DNA line probe assays for rapid detection of multidrug-resistant isolates of Mycobacterium tuberculosis. Indian J. Exp. Biol. 2009, 47(6):454-462.
2. Antonova O.V., et al. Detection of mutations in Mycobacterium tuberculosis genome determining resistance to fluoroquinolones by hybridization on biological microchips. Bull. Exp. Biol. Med. 2008, 145(1):108-113.
3. Anyangwe S.C., Mtonga C. Inequities in the global health workforce: the greatest impediment to health in sub-Saharan Africa. Int. J. Environ. Res. Public Health 2007, 4(2):93-100.
4. Balabanova Y., et al. An integrated approach to rapid diagnosis of tuberculosis and multidrug resistance using liquid culture and molecular methods in Russia. PLoS ONE 2009, 4(9):e7129.
5. Barnard M., et al. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am. J. Respir. Crit. Care Med. 2008, 177(7):787-792.
6. Bemer-Melchior P., Drugeon H.B. Inactivation of Mycobacterium tuberculosis for DNA typing analysis. J. Clin. Microbiol. 1999, 37(7):2350-2351.
7. Bidwell J., et al. DNA heteroduplex technology. Adv Electrophor 1994, (7):311-315.
8. Blakemore R., et al. Evaluation of the analytical performance of the Xpert MTB/RIF assay. J. Clin. Microbiol. 2010, 48(7):2495-2501.
9. Bobadilla-del-Valle M., et al. rpoB Gene mutations in rifampin-resistant Mycobacterium tuberculosis identified by polymerase chain reaction single-stranded conformational polymorphism. Emerg. Infect. Dis. 2001, 7(6):1010-1013.
10. Bravo L.T., et al. Pyrosequencing for rapid detection of Mycobacterium tuberculosis resistance to rifampin, isoniazid, and fluoroquinolones. J. Clin. Microbiol. 2009, 47(12):3985-3990.
11. Bwanga F., et al. Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis. BMC Infect. Dis. 2009, 9:67.
12. Caoili J.C., et al. Evaluation of the TB-Biochip oligonucleotide microarray system for rapid detection of rifampin resistance in Mycobacterium tuberculosis. J. Clin. Microbiol. 2006, 44(7):2378-2381.
13. Caugant D.A., et al. Detection of rifampin resistance among isolates of Mycobacterium tuberculosis from Mozambique. Microb. Drug Resist. 1995, 1(4):321-326.
14. Caws M., et al. PCR-restriction fragment length polymorphism for rapid, low-cost identification of isoniazid-resistant Mycobacterium tuberculosis. J. Clin. Microbiol. 2007, 45(6):1789-1793.
15. Cherkasova E., et al. Microarray analysis of evolution of RNA viruses: evidence of circulation of virulent highly divergent vaccine-derived polioviruses. Proc. Natl Acad. Sci. USA 2003, 100(16):9398-9403.
16. Citron K.M., Girling D.J. Tuberculosis. Crofton and Douglas's Respiratory Diseases 1987, 5:278-299. Oxford University Press/English Language Book Society., Oxford. D.J. Weatherall, J.G.G. Ledingham, D.A. Warrel (Eds.).
17. Cole S.T., et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998, 393(6685):537-544.
18. Denkin S., et al. Microarray-based pncA genotyping of pyrazinamide-resistant strains of Mycobacterium tuberculosis. J. Med. Microbiol. 2005, 54(Pt 12):1127-1131.
19. Djelouadji Z., et al. Pyrosequencing identification of Mycobacterium tuberculosis W-Beijing. BMC Res Notes 2009, 2:239.
20. Doig C., et al. The efficacy of the heat killing of Mycobacterium tuberculosis. J. Clin. Pathol. 2002, 55(10):778-779.
21. Drobniewski F.A., et al. Recommended standards for modern tuberculosis laboratory services in Europe. Eur. Respir. J. 2006, 28(5):903-909.
22. Edwards K.J., et al. Detection of rpoB mutations in Mycobacterium tuberculosis by biprobe analysis. J. Clin. Microbiol. 2001, 39(9):3350-3352.
23. Elbir H., et al. A one-step DNA PCR-based method for the detection of Mycobacterium tuberculosis complex grown on Lowenstein-Jensen media. Am. J. Trop. Med. Hyg. 2008, 78(2):316-317.
24. El-Hajj H.H., et al. Detection of rifampin resistance in Mycobacterium tuberculosis in a single tube with molecular beacons. J. Clin. Microbiol. 2001, 39(11):4131-4137.
25. Espasa M., et al. Direct detection in clinical samples of multiple gene mutations causing resistance of Mycobacterium tuberculosis to isoniazid and rifampicin using fluorogenic probes. J Antimicrob Chemoth 2005, 55:860-865.
26. Evans J., Segal H. Novel multiplex allele-specific PCR assays for the detection of resistance to second-line drugs in Mycobacterium tuberculosis. J Antimicrob Chemother 2010.
27. Felmlee T.A., et al. Genotypic detection of Mycobacterium tuberculosis rifampin resistance: comparison of single-strand conformation polymorphism and dideoxy fingerprinting. J. Clin. Microbiol. 1995, 33(6):1617-1623.
28. Frieden T.R., et al. The emergence of drug-resistant tuberculosis in New York City. N. Engl. J. Med. 1993, 328(8):521-526.
29. Gingeras T.R., et al. Simultaneous genotyping and species identification using hybridization pattern recognition analysis of generic Mycobacterium DNA arrays. Genome Res. 1998, 8(5):435-448.
30. Gryadunov D., et al. Evaluation of hybridisation on oligonucleotide microarrays for analysis of drug-resistant Mycobacterium tuberculosis. Clin. Microbiol. Infect. 2005, 11(7):531-539.
31. Harries A.D., et al. Using a bus service for transporting sputum specimens to the Central Reference Laboratory: effect on the routine TB culture service in Malawi. Int. J. Tuberc. Lung Dis. 2004, 8(2):204-210.
32. Helb D., et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J. Clin. Microbiol. 2010, 48(1):229-237.
33. Heym B., et al. Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study. Lancet 1994, 344(8918):293-298.
34. Hillemann D., et al. Application of the Genotype MTBDR assay directly on sputum specimens. Int. J. Tuberc. Lung Dis. 2006, 10(9):1057-1059.
35. Hillemann D., et al. Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens. J. Clin. Microbiol. 2009, 47(6):1767-1772.
36. Hillemann D., et al. Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J. Clin. Microbiol. 2005, 43(8):3699-3703.
37. Hunt J.M., et al. Detection of a genetic locus encoding resistance to rifampin in mycobacterial cultures and in clinical specimens. Diagn. Microbiol. Infect. Dis. 1994, 18(4):219-227.
38. Huyen M.N., et al. Validation of the GenoType MTBDRplus assay for diagnosis of multidrug resistant tuberculosis in South Vietnam. BMC Infect. Dis. 2010, 10:149.
39. Jarlier V., Nikaido H. Mycobacterial cell wall: structure and role in natural resistance to antibiotics. FEMS Microbiol. Lett. 1994, 123(1-2):11-18.
40. Johnson R., et al. Drug resistance in Mycobacterium tuberculosis. Curr. Issues Mol. Biol. 2006, 8(2):97-111.
41. Jureen P., et al. Rapid detection of rifampin resistance in Mycobacterium tuberculosis by Pyrosequencing technology. J. Clin. Microbiol. 2006, 44(6):1925-1929.
42. Kapur V., et al. Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J. Clin. Microbiol. 1994, 32(4):1095-1098.
43. Kim B.J., et al. Mutations in the rpoB gene of Mycobacterium tuberculosis that interfere with PCR-single-strand conformation polymorphism analysis for rifampin susceptibility testing. J. Clin. Microbiol. 1997, 35(2):492-494.
44. Kwon H.H., et al. Distribution and characterization of beta-lactamases of mycobacteria and related organisms. Tuber. Lung Dis. 1995, 76(2):141-148.
45. Lavender C., et al. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates collected in Australia. Antimicrob. Agents Chemother. 2005, 48:4068-4074.
46. Lee R.E., et al. Mycobacterium tuberculosis cell envelope. Curr. Top. Microbiol. Immunol. 1996, 215:1-27.
47. Lindstrom A., et al. Pyrosequencing for detection of lamivudine-resistant hepatitis B virus. J. Clin. Microbiol. 2004, 42(10):4788-4795.
48. Loman N.J., Pallen M.J. XDR-TB genome sequencing: a glimpse of the microbiology of the future. Future Microbiol. 2008, 3:111-113.
49. Marttila H.J., et al. Prospective evaluation of pyrosequencing for the rapid detection of isoniazid and rifampin resistance in clinical Mycobacterium tuberculosis isolates. Eur. J. Clin. Microbiol. Infect. Dis. 2009, 28(1):33-38.
50. Ministry of Health of Ethiopia. Proceedings of the fifth National TB workshop, Jimma University, October, 2009., pdf. Accessed 5 January 2010.
51. Morcillo N., et al. A low cost, home-made, reverse-line blot hybridisation assay for rapid detection of rifampicin resistance in Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 2002, 6(11):959-965.
52. Morgan M., et al. A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. BMC Infect. Dis. 2005, 5:62.
53. Musser J.M. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin. Microbiol. Rev. 1995, 8(4):496-514.
54. Nair J., et al. The rpsL gene and streptomycin resistance in single and multiple drug-resistant strains of Mycobacterium tuberculosis. Mol. Microbiol. 1993, 10(3):521-527.
55. Nataraj A.J., et al. Single-strand conformation polymorphism and heteroduplex analysis for gel-based mutation detection. Electrophoresis 1999, 20(6):1177-1185.
56. O'Riordan P., et al. Rapid molecular detection of rifampicin resistance facilitates early diagnosis and treatment of multi-drug resistant tuberculosis: case control study. PLoS ONE 2008, 3(9):e3173.
57. Pablos-Mendez A., et al. Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N. Engl. J. Med. 1998, 338(23):1641-1649.
58. Pai S., et al. Routine rapid Mycobacterium species assignment based on species-specific allelic variation in the 65-kilodalton heat shock protein gene (hsp65). Arch. Pathol. Lab. Med. 1997, 121(8):859-864.
59. Park M.M., et al. Outcome of MDR-TB patients, 1983-1993. Prolonged survival with appropriate therapy. Am. J. Respir. Crit. Care Med. 1996, 153(1):317-324.
60. Ridderhof J.C., et al. Roles of laboratories and laboratory systems in effective tuberculosis programmes. Bull. World Health Organ. 2007, 85(5):354-359.
61. Saribas Z., et al. Use of fluorescence resonance energy transfer for rapid detection of isoniazid resistance in Mycobacterium tuberculosis clinical isolates. Int. J. Tuberc. Lung Dis. 2005, 9(2):181-187.
62. Scorpio A., Zhang Y. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat. Med. 1996, 2(6):662-667.
63. Shimizu Y., et al. Five-antituberculosis drug-resistance genes detection using array system. J Clin Biochem Nutr 2008, 42(3):228-234.
64. Somoskovi A., et al. Use of smear-positive samples to assess the PCR-based genotype MTBDR assay for rapid, direct detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin. J. Clin. Microbiol. 2006, 44(12):4459-4463.
65. Stover C.K., et al. A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis. Nature 2000, 405(6789):962-966.
66. Takiff H.E., et al. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob. Agents Chemother. 1994, 38(4):773-780.
67. Telenti A., et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 1993, 341(8846):647-650.
68. Telenti A., et al. Direct, automated detection of rifampin-resistant Mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism analysis. Antimicrob. Agents Chemother. 1993, 37(10):2054-2058.
69. Telenti A., et al. The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nat. Med. 1997, 3(5):567-570.
70. Troesch A., et al. Mycobacterium species identification and rifampin resistance testing with high-density DNA probe arrays. J. Clin. Microbiol. 1999, 37(1):49-55.
71. Turett G.S., et al. Improved outcomes for patients with multidrug-resistant tuberculosis. Clin. Infect. Dis. 1995, 21(5):1238-1244.
72. Vareldzis B.P., et al. Drug-resistant tuberculosis: laboratory issues. World Health Organization recommendations. Tuber. Lung Dis. 1994, 75(1):1-7.
73. Varma-Basil M., et al. Rapid detection of rifampin resistance in Mycobacterium tuberculosis isolates from India and Mexico by a molecular beacon assay. J. Clin. Microbiol. 2004, 42(12):5512-5516.
74. Vester B., Douthwaite S. Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrob. Agents Chemother. 2001, 45(1):1-12.
75. Victor T.C., et al. Prediction of drug resistance in M. tuberculosis: molecular mechanisms, tools, and applications. IUBMB Life 2002, 53(4-5):231-237.
76. Wada T., et al. Dual-probe assay for rapid detection of drug-resistant Mycobacterium tuberculosis by real-time PCR. J. Clin. Microbiol. 2004, 42(11):5277-5285.
77. Watterson S.A., et al. Comparison of three molecular assays for rapid detection of rifampin resistance in Mycobacterium tuberculosis. J. Clin. Microbiol. 1998, 36(7):1969-1973.
78. Whelen A.C., et al. Direct genotypic detection of Mycobacterium tuberculosis rifampin resistance in clinical specimens by using single-tube heminested PCR. J. Clin. Microbiol. 1995, 33(3):556-561.
79. WHO Global tuberculosis control: WHO Report 1999. WHO/CDC/CPC/TB/99.259 1999, World Health Organization, Geneva.
80. WHO New laboratory diagnostic tools for tuberculosis control. Available http://apps.who.int/tdr/publications/non-tdr-publications/diagnostic-tool-tb/pdf/diagnostic-tool-tb.pdf.
81. Yesilkaya H., et al. Evaluation of molecular-Beacon, TaqMan, and fluorescence resonance energy transfer probes for detection of antibiotic resistance-conferring single nucleotide polymorphisms in mixed Mycobacterium tuberculosis DNA extracts. J. Clin. Microbiol. 2006, 44(10):3826-3829.
82. Yip C.W., et al. Denaturing HPLC for high-throughput screening of rifampicin-resistant Mycobacterium tuberculosis isolates. Int. J. Tuberc. Lung Dis. 2006, 10(6):625-630.
83. Zhang Y., Telenti A. Genetics of drug resistance in Mycobacterium tuberculosis. Molecular Genetics of Mycobacteria 2000, 235-254. ASM Press, Washington D.C. G.F. Hatful, W.R. Jacobs (Eds.).
84. Zhang Y., Yew W.W. Mechanisms of drug resistance in Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 2009, 13(11):1320-1330.
85. Zhao J.R., et al. Development of a pyrosequencing approach for rapid screening of rifampin, isoniazid and ethambutol-resistant Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 2005, 9(3):328-332.